Cargando…
Comparative Assessment of Adherence Measures and Resource Use in SSRI/SNRI-Treated Patients with Depression Using Second-Generation Antipsychotics or L-Methylfolate as Adjunctive Therapy
BACKGROUND: Antidepressant monotherapy is effective in achieving treatment remission in only approximately one third of patients with depression, and even switching to a second antidepressant brings the cumulative remission rate to only 50%-55%. This has led to an interest in augmentation therapy fo...
Autores principales: | Wade, Rolin L., Kindermann, Sylvia L., Hou, Qingjiang, Thase, Michael E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438233/ https://www.ncbi.nlm.nih.gov/pubmed/24372461 http://dx.doi.org/10.18553/jmcp.2014.20.1.76 |
Ejemplares similares
-
Risks of using SSRI / SNRI antidepressants during pregnancy and lactation
por: Dubovicky, Michal, et al.
Publicado: (2017) -
Placebo Responses and Their Clinical Implications in Fibromyalgia: A Meta-Analysis Using SSRI and SNRI Trials
por: Koechlin, Helen, et al.
Publicado: (2021) -
Plasma concentrations of SSRI/SNRI after bariatric surgery and the effects on depressive symptoms
por: Pasi, Patrick, et al.
Publicado: (2023) -
Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden
por: Zoega, Helga, et al.
Publicado: (2015) -
Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding: A Nationwide Population-Based Cohort Study in Taiwan
por: Cheng, Yuan-Lung, et al.
Publicado: (2015)